Azelis Group (AZE) Q1 2026 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 TU earnings summary
23 Apr, 2026Executive summary
Q1 2026 revenue reached EUR 1.0bn, down 0.7% year-on-year in constant currency, with a 3.9% organic decline partially offset by 3.3% growth from acquisitions.
Adjusted EBITA was EUR 104m, with margin down to 10.0%, reflecting a 12.7% year-over-year decline and cost discipline partially offsetting lower revenue.
Free cash flow was EUR 119m, with a 113% cash conversion ratio, highlighting strong cash generation and asset-light business model.
Net debt reduced to EUR 1.5bn, leverage at 3.4x, and liquidity at EUR 799m.
Strategic focus remains on cost discipline, cash generation, and executing key programs while navigating volatility.
Financial highlights
Revenue of EUR 1.0bn, down 0.7% year-on-year at constant currency; 5.2% decline on a reported basis due to FX headwinds.
Gross profit was EUR 246m, margin 23.7%, down 2.3% year-on-year, with a 38 bp contraction due to negative mix effects.
Adjusted EBITA margin declined to 10.0%, down 86 bp year-on-year.
Free cash flow conversion ratio improved to 113% from 100% prior year.
Net working capital to revenue ratio improved to 13.9% from 14.7% prior year.
Outlook and guidance
Persistent volatility expected due to geopolitical tensions, with only moderate near-term uplift from pre-buying or price inflation.
Focus remains on cost management, cash generation, and capturing upside as market conditions gradually recover.
The business model is considered resilient and well-positioned for long-term industry trends.
Latest events from Azelis Group
- Revenue up 1.3% to €4.1bn, net profit down to €113m, strong cash flow and four acquisitions.AZE
H2 202510 Apr 2026 - Stable revenue, margin gains, and acquisitions amid profit and cash flow pressure.AZE
H1 20242 Feb 2026 - Q3 2024 saw organic growth and margin gains, with acquisitions driving resilient performance.AZE
Q3 2024 TU18 Jan 2026 - Revenue and margins improved in 2024, with strong M&A activity and positive outlook for 2025.AZE
H2 202425 Dec 2025 - Revenue up 4.5% to EUR 1.1bn, but margin pressure led to cost-saving measures.AZE
Q1 2025 TU29 Nov 2025 - Revenue up 0.6% to €2.2bn, profit down 14.6%, but cash flow and acquisitions boost outlook.AZE
H1 202516 Nov 2025 - Free cash flow up 34% and margin pressure, with four acquisitions and higher leverage.AZE
Q3 2025 TU23 Oct 2025 - Azelis drives growth and innovation in specialty chemicals distribution with strong financial returns.AZE
Investor Lab Tour 2024 Istanbul Presentation13 Jun 2025